Washington, DC: Food and Drug Administration [FDA], 2010 January 13: ? p. [Online]. Accessed: http://www.regulations.gov [2010 February 15]
Showing items related by title, author, creator and subject.
Guidance for Industry. IRB Review of Stand-Alone HIPAA Authorizations Under FDA Regulations: Final Guidance Unknown creator (United States. Food and Drug Administration [FDA]. Office of the Commissioner, 2003-10-21)
Application of the Three Rs Principle in the Compilation of "Technical Guidance Document in Support of Directive 98/8/EC Concerning the Placing of Biocidal Products on the Market, Part I, Guidance on Data Requirements for Active Substances And Biocidal Products" Sauer, Ursula G.; Liebsch, Manfred; Kolar, Roman (2000)
Guidance for Industry. Using a Centralized IRB Review Process in Multicenter Clinical Trials. Draft Guidance Unknown creator (United States. Food and Drug Administration [FDA]; Good Clinical Practice Program, Office of the Commissioner [OC]; Center for Drug Evaluation and Research [CDER]; Center for Biologics Evaluation and Research [CBER]; Office of Regulatory Affairs [ORA], 2005-03)